Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Hypergammaglobulinemia sustains the development of regulatory responses during chronic Leishmania donovani infection in mice.

Silva-Barrios S, Stäger S.

Eur J Immunol. 2019 Jul;49(7):1082-1091. doi: 10.1002/eji.201847917. Epub 2019 May 23.

PMID:
31001826
2.

IRF-5 Promotes Cell Death in CD4 T Cells during Chronic Infection.

Fabié A, Mai LT, Dagenais-Lussier X, Hammami A, van Grevenynghe J, Stäger S.

Cell Rep. 2018 Jul 31;24(5):1163-1175. doi: 10.1016/j.celrep.2018.06.107.

3.

Deciphering natural control of HIV-1: A valuable strategy to achieve antiretroviral therapy termination.

Loucif H, Gouard S, Dagenais-Lussier X, Murira A, Stäger S, Tremblay C, Van Grevenynghe J.

Cytokine Growth Factor Rev. 2018 Apr;40:90-98. doi: 10.1016/j.cytogfr.2018.03.010. Epub 2018 Apr 5. Review.

PMID:
29778137
4.

eIF4E-Binding Proteins 1 and 2 Limit Macrophage Anti-Inflammatory Responses through Translational Repression of IL-10 and Cyclooxygenase-2.

William M, Leroux LP, Chaparro V, Lorent J, Graber TE, M'Boutchou MN, Charpentier T, Fabié A, Dozois CM, Stäger S, van Kempen LC, Alain T, Larsson O, Jaramillo M.

J Immunol. 2018 Jun 15;200(12):4102-4116. doi: 10.4049/jimmunol.1701670. Epub 2018 Apr 30.

5.

HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis.

Hammami A, Abidin BM, Heinonen KM, Stäger S.

Sci Rep. 2018 Feb 22;8(1):3500. doi: 10.1038/s41598-018-21891-z.

6.

Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.

Dagenais-Lussier X, Loucif H, Murira A, Laulhé X, Stäger S, Lamarre A, van Grevenynghe J.

Viruses. 2017 Dec 30;10(1). pii: E12. doi: 10.3390/v10010012. Review.

7.

The Deadly Dance of B Cells with Trypanosomatids.

Silva-Barrios S, Charpentier T, Stäger S.

Trends Parasitol. 2018 Feb;34(2):155-171. doi: 10.1016/j.pt.2017.10.001. Epub 2017 Oct 28. Review.

PMID:
29089182
8.

HIF-1α is a key regulator in potentiating suppressor activity and limiting the microbicidal capacity of MDSC-like cells during visceral leishmaniasis.

Hammami A, Abidin BM, Charpentier T, Fabié A, Duguay AP, Heinonen KM, Stäger S.

PLoS Pathog. 2017 Sep 11;13(9):e1006616. doi: 10.1371/journal.ppat.1006616. eCollection 2017 Sep.

9.

Infection-adapted emergency hematopoiesis promotes visceral leishmaniasis.

Abidin BM, Hammami A, Stäger S, Heinonen KM.

PLoS Pathog. 2017 Aug 7;13(8):e1006422. doi: 10.1371/journal.ppat.1006422. eCollection 2017 Aug.

10.

Treatment effectiveness for aging changes in the larynx.

Sachs AM, Bielamowicz SA, Stager SV.

Laryngoscope. 2017 Nov;127(11):2572-2577. doi: 10.1002/lary.26706. Epub 2017 Jul 6.

PMID:
28681923
11.

Protozoan Parasites and Type I IFNs.

Silva-Barrios S, Stäger S.

Front Immunol. 2017 Jan 19;8:14. doi: 10.3389/fimmu.2017.00014. eCollection 2017. Review.

12.

Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells.

Laroche-Lefebvre C, Yousefi M, Daudelin JF, Charpentier T, Tarrab E, Klinck R, Lamarre A, Labrecque N, Stäger S, Duplay P.

J Immunol. 2016 Nov 1;197(9):3618-3627. Epub 2016 Sep 23.

13.

Hypoxia inducible factor 1α: A critical factor for the immune response to pathogens and Leishmania.

Charpentier T, Hammami A, Stäger S.

Cell Immunol. 2016 Nov;309:42-49. doi: 10.1016/j.cellimm.2016.06.002. Epub 2016 Jun 22. Review.

PMID:
27372381
14.

Innate Immune B Cell Activation by Leishmania donovani Exacerbates Disease and Mediates Hypergammaglobulinemia.

Silva-Barrios S, Smans M, Duerr CU, Qureshi ST, Fritz JH, Descoteaux A, Stäger S.

Cell Rep. 2016 Jun 14;15(11):2427-37. doi: 10.1016/j.celrep.2016.05.028. Epub 2016 Jun 2.

15.

Characteristics of Fluency and Speech in Two Families With High Incidences of Stuttering.

Stager SV, Freeman FJ, Braun A.

J Speech Lang Hear Res. 2015 Oct;58(5):1440-51. doi: 10.1044/2015_JSLHR-S-14-0080.

16.

IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection.

Hammami A, Charpentier T, Smans M, Stäger S.

PLoS Pathog. 2015 Jun 5;11(6):e1004938. doi: 10.1371/journal.ppat.1004938. eCollection 2015 Jun.

17.

Vocal fold paresis: etiology, clinical diagnosis and clinical management.

Stager SV.

Curr Opin Otolaryngol Head Neck Surg. 2014 Dec;22(6):444-9. doi: 10.1097/MOO.0000000000000112. Review.

PMID:
25254404
18.

Leishmania promastigotes induce cytokine secretion in macrophages through the degradation of synaptotagmin XI.

Arango Duque G, Fukuda M, Turco SJ, Stäger S, Descoteaux A.

J Immunol. 2014 Sep 1;193(5):2363-72. doi: 10.4049/jimmunol.1303043. Epub 2014 Jul 25.

19.

The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.

Sarzotti-Kelsoe M, Needham LK, Rountree W, Bainbridge J, Gray CM, Fiscus SA, Ferrari G, Stevens WS, Stager SL, Binz W, Louzao R, Long KO, Mokgotho P, Moodley N, Mackay M, Kerkau M, McMillion T, Kirchherr J, Soderberg KA, Haynes BF, Denny TN.

J Immunol Methods. 2014 Jul;409:21-30. doi: 10.1016/j.jim.2014.05.013. Epub 2014 Jun 5.

20.

Perceived vocal fatigue and effort in relation to laryngeal functional measures in paresis patients.

Stager SV, Bielamowicz SA.

Laryngoscope. 2014 Jul;124(7):1631-7. doi: 10.1002/lary.24493. Epub 2013 Dec 13.

PMID:
24338804
21.

CD8(+) T cells in leishmania infections: friends or foes?

Stäger S, Rafati S.

Front Immunol. 2012 Jan 24;3:5. doi: 10.3389/fimmu.2012.00005. eCollection 2012.

22.

Marginal zone B cells regulate antigen-specific T cell responses during infection.

Bankoti R, Gupta K, Levchenko A, Stäger S.

J Immunol. 2012 Apr 15;188(8):3961-71. doi: 10.4049/jimmunol.1102880. Epub 2012 Mar 12.

23.

Selective left, right and bilateral stimulation of subthalamic nuclei in Parkinson's disease: differential effects on motor, speech and language function.

Schulz GM, Hosey LA, Bradberry TJ, Stager SV, Lee LC, Pawha R, Lyons KE, Metman LV, Braun AR.

J Parkinsons Dis. 2012;2(1):29-40. doi: 10.3233/JPD-2012-11049.

PMID:
23939406
24.

Differential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani.

Bankoti R, Stäger S.

J Trop Med. 2012;2012:639304. doi: 10.1155/2012/639304. Epub 2011 Jul 21.

25.

Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.

Paun A, Bankoti R, Joshi T, Pitha PM, Stäger S.

PLoS Pathog. 2011 Jan 6;7(1):e1001246. doi: 10.1371/journal.ppat.1001246.

26.

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

Stäger S, Joshi T, Bankoti R.

Immunol Res. 2010 Jul;47(1-3):14-24. doi: 10.1007/s12026-009-8135-4. Review.

PMID:
20087685
27.

Using laryngeal electromyography to differentiate presbylarynges from paresis.

Stager SV, Bielamowicz SA.

J Speech Lang Hear Res. 2010 Feb;53(1):100-13. doi: 10.1044/1092-4388(2009/08-0244). Epub 2009 Nov 30.

PMID:
19948754
28.

Evidence of return of function in patients with vocal fold paresis.

Stager SV, Bielamowicz SA.

J Voice. 2010 Sep;24(5):614-22. doi: 10.1016/j.jvoice.2008.12.012. Epub 2009 Nov 1.

PMID:
19883992
29.

A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome.

Ranatunga D, Hedrich CM, Wang F, McVicar DW, Nowak N, Joshi T, Feigenbaum L, Grant LR, Stäger S, Bream JH.

Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17123-8. doi: 10.1073/pnas.0904955106. Epub 2009 Sep 9.

30.

B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections.

Joshi T, Rodriguez S, Perovic V, Cockburn IA, Stäger S.

PLoS Pathog. 2009 May;5(5):e1000431. doi: 10.1371/journal.ppat.1000431. Epub 2009 May 15.

31.

Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.

Maroof A, Beattie L, Zubairi S, Svensson M, Stager S, Kaye PM.

Immunity. 2008 Aug 15;29(2):295-305. doi: 10.1016/j.immuni.2008.06.012.

32.

Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.

Stäger S, Maroof A, Zubairi S, Sanos SL, Kopf M, Kaye PM.

Eur J Immunol. 2006 Jul;36(7):1764-71.

34.

Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

Polley R, Stager S, Prickett S, Maroof A, Zubairi S, Smith DF, Kaye PM.

Infect Immun. 2006 Jan;74(1):773-6.

35.

Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter.

Stager SV, Calis K, Grothe D, Bloch M, Berensen NM, Smith PJ, Braun A.

J Fluency Disord. 2005;30(4):319-35. Epub 2005 Oct 24.

PMID:
16246409
36.

Perceptual ratings of vocal characteristics and voicing features in untreated patients with unilateral vocal fold paralysis.

Leydon C, Bielamowicz S, Stager SV.

J Commun Disord. 2005 May-Jun;38(3):163-85.

PMID:
15748722
37.

Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Engwerda CR, Ato M, Stäger S, Alexander CE, Stanley AC, Kaye PM.

Am J Pathol. 2004 Dec;165(6):2123-33.

38.

The immunopathology of experimental visceral leishmaniasis.

Kaye PM, Svensson M, Ato M, Maroof A, Polley R, Stager S, Zubairi S, Engwerda CR.

Immunol Rev. 2004 Oct;201:239-53. Review.

PMID:
15361245
39.

CD8+ T-cell priming regulated by cytokines of the innate immune system.

Stäger S, Kaye PM.

Trends Mol Med. 2004 Aug;10(8):366-71. Review.

PMID:
15310456
40.
41.

Common features of fluency-evoking conditions studied in stuttering subjects and controls: an H(2)15O PET study.

Stager SV, Jeffries KJ, Braun AR.

J Fluency Disord. 2003 Winter;28(4):319-35; quiz 336. Review.

PMID:
14643068
42.

Incidence of supraglottic activity in males and females: a preliminary report.

Stager SV, Neubert R, Miller S, Regnell JR, Bielamowicz SA.

J Voice. 2003 Sep;17(3):395-402.

PMID:
14513962
43.

Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

Stäger S, Alexander J, Kirby AC, Botto M, Rooijen NV, Smith DF, Brombacher F, Kaye PM.

Nat Med. 2003 Oct;9(10):1287-92. Epub 2003 Sep 21.

PMID:
14502281
44.
45.

Surgical access to the internal nasal valve.

Gupta A, Brooks D, Stager S, Lindsey WH.

Arch Facial Plast Surg. 2003 Mar-Apr;5(2):155-8.

PMID:
12633203
46.

Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis.

Ato M, Stäger S, Engwerda CR, Kaye PM.

Nat Immunol. 2002 Dec;3(12):1185-91. Epub 2002 Nov 18.

PMID:
12436111
47.

Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort.

Bielamowicz S, Villagomez V, Stager SV, Wilson WR.

Laryngoscope. 2002 Apr;112(4):696-9.

PMID:
12150526
48.

Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.

Bielamowicz S, Stager SV, Badillo A, Godlewski A.

J Voice. 2002 Mar;16(1):117-23.

PMID:
12002878
49.

Quantification of static and dynamic supraglottic activity.

Stager SV, Bielamowicz S, Gupta A, Marullo S, Regnell JR, Barkmeier J.

J Speech Lang Hear Res. 2001 Dec;44(6):1245-56.

PMID:
11776362

Supplemental Content

Loading ...
Support Center